In glioblastoma patients, the Ang-1/Ang-2 ratio correlates with survival [29] and vascular normalization, whereas high Ang-2 levels correlate with resistance to anti-VEGF therapy [30]. The gene discussed is VEGFA; the disease is glioblastoma.